Mycobacterium haemophilum Infection

Back

Background

Mycobacterium haemophilum is a nontuberculous mycobacterium that causes skin, joint, bone, and pulmonary infections in immunocompromised persons and lymphadenitis in children.[1, 2]

M haemophilum was first isolated from subcutaneous abscesses in a patient with Hodgkin disease. Most recent infections have occurred in patients with AIDS, in transplant recipients, and in patients receiving tumor necrosis factor-alpha inhibitors.[3, 4, 5] M haemophilum skin infection has been associated with permanent eyebrow makeup and tattoos,[6] as well as acupuncture treatments.[7]

M haemophilum is a fastidious (requires special growth media) mycobacterium that requires heme-supplemented culture media and low temperatures for growth. Because of these features, it is probably underdiagnosed.

Pathophysiology

The pathophysiology, natural habitat, and mechanism for acquisition of M haemophilum infection are not known. Water reservoirs may be the source of M haemophilum infections. Immunocompromised adults with M haemophilum infection most commonly present with skin lesions. Septic arthritis and osteomyelitis may also occur. Pulmonary infection is much less common and may follow skin disease. M haemophilum infection occasionally causes pulmonary infection initially. Mycobacteremia may occur.

Epidemiology

Frequency

United States

More than 40 cases of M haemophilum infection have been reported, including 10 cases in Arizona from 1984-1994. Most cases occurred in immunosuppressed patients. The incidence of disease is unknown.

International

Cases of M haemophilum infection have been reported sporadically from Australia, France, Germany,[8] Canada, Israel, United Kingdom, and South Africa.

Mortality/Morbidity

In healthy children, localized cervical lymphadenopathy is a benign disease that responds well to excision of the involved lymph nodes.

In immunocompromised patients, the outcome of disease is determined by the degree of underlying immunosuppression. Some patients with AIDS respond to therapy, while others respond initially but relapse later. Fatalities have occurred in bone marrow transplant recipients.

Sex

M haemophilum infection is more common in males than in females. This may be related to the higher incidence of HIV infection in males.

Age

Lymphadenitis occurs in young children.

Most cases in immunocompromised patients occur in adults.

Prognosis

Prognosis for children with localized lymphadenitis is good.

In adults, the outcome is determined by their immune function.

In severely immunosuppressed patients, disease may require long-term therapy. Despite maintenance therapy, infection may persist or recur.

Patient Education

Adherence to medication is of utmost importance to prevent resistance.

Instruct patients to list all medications to avoid drug interactions.

Rifampin and rifabutin may interfere with contraceptives and numerous other medications, especially HIV-related therapy.

History

Lymphadenitis in children

The most common symptom is swelling of the neck, which slowly enlarges over several weeks to months. The enlarged nodes may be painful. A course of antimicrobial therapy (eg, 2 wk of oral amoxicillin/clavulanic acid) does not cure the swelling.

Inguinal lymphadenitis has also been reported.[9]

Systemic symptoms are absent except for low-grade fever.

Lymphadenitis in adults

Six cases have occurred in immunocompetent adults.[10]

Cervicofacial lymphadenitis has been reported in immunocompromised adults.[11]

Skin lesions

Skin lesions are the most common presenting symptom in immunosuppressed patients.

Lesions usually develop on the extremities over joints. They may begin as papules, subcutaneous nodules, scales, or cysts and are initially painless but often become tender and pruritic. Painful ulcerations may occur. Erythema may surround the lesion.

Lesions may resemble sporotrichosis.[12]

Oculofacial lesions have been reported in an immunocompetent child.[13]

Erythematous plaques and subcutaneous nodules of the face mimicking leprosy have been reported.[14, 15]

Nodular skin lesions have occurred after permanent tattooing of eyebrows in 2 women.[16]

Tattoo-associated skin lesions have occurred in immunocompetent adults[17]

Skin lesions have been reported prior to onset of B cell lymphoma in a liver transplant recipient.[18]

Septic arthritis

Patients present with pain and swelling over a joint, usually the knee or elbow. Often, the patient has a history of cutaneous lesions overlying the joint.[19]

Pyomyositis

This has been reported in a renal transplant recipient.[20]

Osteomyelitis

This is reported in patients with AIDS.

Skin lesions are usually present.

Septic arthritis is usually present.

Pneumonia

Symptoms include fever, cough, pleuritic chest pain, and dyspnea.

Patients may have a history of treated cutaneous lesions.

This is reported in bone marrow transplant recipients and patients with AIDS.[21, 22, 23]

Central venous catheter tunnel infection

Two cases in immunosuppressed patients have been reported. The first patient presented with a supraclavicular mass with overlying cellulitis that progressed to ulceration. The second patient had an ulceration and purulent discharge at the former site of a Hickman catheter.[24]

Chronic cutaneous granulomata

One case was described in a previously healthy man following a coral injury in Thailand.[25]

Endophthalmitis

This has been reported in a cardiac transplant patient.[26]

Epididymal abscess

This has been reported in a renal transplant patient.[27]

Central nervous system infection

This has been reported in patients with AIDS.[28, 29]

Physical

Lymphadenitis

The submandibular and cervical nodes are most frequently involved. Perihilar nodes are involved less frequently. Enlarged nodes are usually unilateral and may be tender and fluctuant. Overlying skin may be erythematous.

Low-grade fever may be present.

Skin lesions

Lesions include the following:

Initially, they are painless but may become painful or pruritic.

They may be localized on extremities over joints, or they may be diffuse.

Septic arthritis

The major finding is a swollen fluctuant knee.

Osteomyelitis

Septic arthritis is also present.

Pneumonia

Fever is present.

Central venous catheter tunnel infection

Ulcerations develop at the exit site and along the catheter track.

Lymphadenopathy

Lymphadenopathy may occur.

Causes

Risk factors for M haemophilum infection include the following:

Laboratory Studies

Evaluate the CBC count, liver enzymes, and serum electrolyte levels, including creatinine.

Acid-fast bacillus smear and culture

M haemophilum is a slow-growing, acid-fast–positive, nontuberculous mycobacterium that requires media supplemented with ferric iron–containing compounds and grows best at 30-32°C. Growth on solid media usually takes 2-3 weeks. The organism typically does not stain with Gram stain.

Aspirate of lesions may reveal acid-fast bacilli.

Perform an acid-fast bacillus (AFB) smear on excised lymph nodes. Culture a specimen at 30-32°C in media supplemented with iron or heme.

In patients with septic arthritis and osteomyelitis, submit synovial fluid specimens and bone biopsy samples for AFB smear and culture. Synovial fluid is usually purulent, and M haemophilum may be isolated from the fluid.

Submit sputum from immunosuppressed patients with pneumonia for AFB smear and culture. M haemophilum can be cultured from the blood of some patients with AIDS using special isolator tubes.

In appropriate clinical settings (eg, skin lesions, lymphadenopathy), informing the mycobacteriology laboratory to culture for M haemophilum may be useful. Iron must be added to grow this organism.

M haemophilum is unlikely to be a saprophyte (an innocent bystander) or a laboratory contaminant in the appropriate clinical setting.

Polymerase chain reaction (PCR)–restriction endonuclease analysis has been used for direct identification of M haemophilum in clinical specimens from immunocompromised patients.[37, 38, 39, 40]

M haemophilum –specific PCR has been used to diagnosis M haemophilum cervicofacial lymphadenitis in children and was superior to culture in one series of patients from the Netherlands.[41]

Imaging Studies

Radiography of involved joints or bone may demonstrate soft tissue swelling and lytic lesions. Chest radiograph findings are abnormal in patients with pneumonia. Unilateral or bilateral infiltrates may appear.

CT scans of the chest may reveal abnormalities that are not revealed with chest radiography. Regular cuts of 5-7 mm should be sufficient; high-resolution CT scan is rarely necessary.

MRI demonstrates medullary lesions and cortical disruption.

Diagnosis has been made using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) scanning.[42]

Other Tests

In children with lymphadenitis a tuberculin skin test result with purified protein derivative (PPD) of tuberculosis may be positive; however, it is rarely larger than 9 mm.[43]

Procedures

Aspirate of lesions may reveal AFB.

Histologic Findings

Biopsy specimens of skin lesions show granulomatous panniculitis and caseating or noncaseating granulomas. Patients with AIDS have poorly formed granulomas. A neutrophilic infiltrate with multinucleated giant cells may be observed. AFB smear results are usually positive, revealing large, pleomorphic, or curved AFB.

Lymph node biopsy may reveal granulomas, necrosis, granulating tissue, or multinucleated giant cells, and the specimen may be smear-positive for AFB.

Medical Care

Treatment is determined by the degree of immunosuppression. In healthy children with lymphadenitis, surgical excision is the preferred treatment. In immunosuppressed patients, reversal of immunosuppression is the most effective treatment. Immunosuppressed patients require combination therapy to prevent the development of resistance. Susceptibility testing is not standardized, but M haemophilum is usually susceptible to amikacin, ciprofloxacin, and other quinolones (eg, levofloxacin, moxifloxacin), clarithromycin, rifabutin, rifampin. M haemophilum is usually resistant to ethambutol, ethionamide, isoniazid, and streptomycin. Although the optimal regimen is not known, combinations have had some clinical success.

Effective drug combinations include the following:

Surgical Care

Lymphadenitis in children: Total excision of the involved lymph node or nodes is the treatment of choice.[44]

Consultations

See the list below:

Further Outpatient Care

Patients require close outpatient follow-up care to document response to therapy (eg, every 2-4 wk). Length of therapy is prolonged in immunosuppressed patients, and patients with irreversible immunosuppression may require life-long suppressive therapy. Relapses have occurred in patients with AIDS who were on suppressive therapy. Whether patients on highly active antiretroviral therapy (HAART) can stop therapy if they have a good HAART response is unknown.

Discuss adherence to medications extensively with the patient to avoid development of resistance.

Further Inpatient Care

M haemophilum infection is diagnosed in many immunosuppressed patients who are hospitalized.

Treatment can be started or continued on an outpatient basis in most patients.

Medication Summary

Although no standardized treatment exists, a regimen that includes a combination of at least 2 drugs with low minimum inhibitory concentrations (MICs) against M haemophilum is preferred.

A 3-drug combination of ciprofloxacin, clarithromycin, and rifampin or rifabutin has been used for cutaneous disease in bone marrow transplant recipients. No standard treatment exists; optimal treatment time is unknown.

Clarithromycin (Biaxin XL)

Clinical Context:  Macrolide with activity against various nontuberculous mycobacteria. Binds to bacterial 50S ribosomal subunit and inhibits RNA-dependent protein synthesis.

Rifampin (Rifadin, Rimactane)

Clinical Context:  Important drug used in the treatment of infection with M tuberculosis and nontuberculous mycobacterial infections. Inhibits DNA-dependent RNA polymerase activity.

Ciprofloxacin (Cipro)

Clinical Context:  Fluoroquinolone that inhibits bacterial DNA synthesis and, consequently, growth. Other quinolones such as levofloxacin, sparfloxacin, and ofloxacin may also be effective.

Amikacin (Amikin)

Clinical Context:  Expected to be a powerful drug for mycobacteremia. Starting amikacin may be beneficial at least as long as the patient is septic.

Class Summary

Empiric antimicrobial therapy must be comprehensive and should cover all likely pathogens in the context of the clinical setting.

Author

Shirin A Mazumder, MD, FIDSA, Associate Professor of Medicine, Director of Infectious Disease Fellowship Program, Division of Infectious Diseases, Department of Internal Medicine, University of Tennessee Health Science Center College of Medicine, University of Tennessee Methodist Physicians

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Aaron Glatt, MD, Chairman, Department of Medicine, Chief, Division of Infectious Diseases, Hospital Epidemiologist, South Nassau Communities Hospital

Disclosure: Nothing to disclose.

Chief Editor

Pranatharthi Haran Chandrasekar, MBBS, MD, Professor, Chief of Infectious Disease, Department of Internal Medicine, Wayne State University School of Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Klaus-Dieter Lessnau, MD, FCCP, Former Clinical Associate Professor of Medicine, New York University School of Medicine; Medical Director, Pulmonary Physiology Laboratory, Director of Research in Pulmonary Medicine, Department of Medicine, Section of Pulmonary Medicine, Lenox Hill Hospital

Disclosure: Nothing to disclose.

Natalie C Klein, MD, PhD, Associate Director, Infectious Disease Division, Associate Professor of Medicine, The School of Medicine at Stony Brook University Medical Center

Disclosure: Nothing to disclose.

References

  1. Minani TJ, Saubolle MA, Yu E, Sussland Z. Mycobacterium haemophilum as a novel etiology of cervical lymphadenitis in an otherwise healthy adult patient. J Clin Microbiol. 2010 Jul. 48(7):2636-9. [View Abstract]
  2. Bittner MJ, Preheim LC. Other Slow-Growing Nontuberculous Mycobacteria. Microbiol Spectr. 2016 Nov. 4 (6):[View Abstract]
  3. Collins CS, Terrell C, Mueller P. Disseminated Mycobacterium haemophilum infection in a 72-year-old patient with rheumatoid arthritis on infliximab. BMJ Case Rep. 2013 Mar 15. 2013:[View Abstract]
  4. Aslam A, Green RL, Motta L, Ghrew M, Griffiths CE, Warren RB. Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis. Br J Dermatol. 2013 Feb. 168(2):446-7. [View Abstract]
  5. Swart RM, van Ingen J, van Soolingen D, Slingerland R, Hendriks WD, den Hollander JG. Nontuberculous mycobacteria infection and tumor necrosis factor-alpha antagonists. Emerg Infect Dis. 2009 Oct. 15(10):1700-1. [View Abstract]
  6. Giulieri S, Morisod B, Edney T, Odman M, Genné D, Malinverni R, et al. Outbreak of Mycobacterium haemophilum infections after permanent makeup of the eyebrows. Clin Infect Dis. 2011 Feb 15. 52(4):488-91. [View Abstract]
  7. Castro-Silva AN, Freire AO, Grinbaum RS, Elmor de Araújo MR, Abensur H, Araújo MR, et al. Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment. Transpl Infect Dis. 2011 Feb. 13(1):33-7. [View Abstract]
  8. Hamsch C, Hartschuh W, Enk A, Flux K. A Chinese tattoo paint as a vector of atypical mycobacteria-outbreak in 7 patients in Germany. Acta Derm Venereol. 2011 Jan. 91(1):63-4. [View Abstract]
  9. Lindeboom JA, Kuijper CF, van Furth M. Inguinal lymphadenitis caused by mycobacterium haemophilum in an immunocompetent child. Pediatr Infect Dis J. 2007 Jan. 26(1):84-6. [View Abstract]
  10. Mycobacterium haemophilum as a novel etiology of cervical lymphadenitis in an otherwise healthy adult patient. J Clin Microbiol. Jul 2010:2636-9.
  11. Atiya N, Sulaiman H, Chong J, Ng KP. First report of cervicofacial lymphadenitis due to Mycobacterium haemophilum in an immunocompromised adult patient. J Infect Dev Ctries. 2015 Mar 15. 9 (3):313-6. [View Abstract]
  12. Gao W, Chen H, Wang H, Jiang H, Liu W, Hao D, et al. Bilateral Sporotrichoid Cutaneous Infection by Mycobacterium haemophilum in a Chinese Patient with Systemic Lupus Erythematosus. Acta Derm Venereol. 2015 Jun 24. 95 (6):760-1. [View Abstract]
  13. Lindeboom JA, Kuijper EJ, Bruijnesteijn van Coppenraet ES, Prins JM. First case of an oculofacial lesion due to Mycobacterium haemophilum infection in an immunocompetent child. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jun. 101(6):774-6. [View Abstract]
  14. Copeland NK, Arora NS, Ferguson TM. Mycobacterium haemophilum Masquerading as Leprosy in a Renal Transplant Patient. Case Rep Dermatol Med. 2013. 2013:793127. [View Abstract]
  15. Ishii K, Ishii N, Nakanaga K, Nakano K, Saito I, Asahina A. Mycobacterium haemophilum infection with prominent facial manifestation mimicking leprosy. J Dermatol. 2015 May 28. [View Abstract]
  16. Wollina U. Nodular skin reactions in eyebrow permanent makeup: two case reports and an infection by Mycobacterium haemophilum. J Cosmet Dermatol. 2011 Sep. 10(3):235-9. [View Abstract]
  17. Kay MK, Perti TR, Duchin JS. Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009. Emerg Infect Dis. 2011 Sep. 17(9):1734-6. [View Abstract]
  18. Doherty T, Lynn M, Cavazza A, Sames E, Hughes R. Mycobacterium haemophilum as the Initial Presentation of a B-Cell Lymphoma in a Liver Transplant Patient. Case Rep Rheumatol. 2014. 2014:742978. [View Abstract]
  19. Izawa K, Kitada S. CLINICAL ANALYSIS OF OSTEOARTICULAR NONTUBERCULOUS MYCOBACTERIAL INFECTION. Kekkaku. 2016 Jan. 91 (1):1-8. [View Abstract]
  20. Jang EY, Lee SO, Choi SH, Sung H, Kim MN, Kim BJ, et al. Case of pyomyositis due to Mycobacterium haemophilum in a renal transplant recipient. J Clin Microbiol. 2007 Nov. 45(11):3847-9. [View Abstract]
  21. Kiehn TE, White M. Mycobacterium haemophilum: an emerging pathogen. Eur J Clin Microbiol Infect Dis. 1994 Nov. 13(11):925-31. [View Abstract]
  22. Sturenburg EE, Horstkotte MA, Aberle J, Meyer K, Richter E, Laufs R, et al. Disseminated Mycobacterium haemophilum infection as initial manifestation of AIDS. Tuberculosis (Edinb). 2004. 84(6):341-5. [View Abstract]
  23. White MH, Papadopoulos EB, Small TN, Kiehn TE, Armstrong D. Mycobacterium haemophilum infections in bone marrow transplant recipients. Transplantation. 1995 Nov 15. 60(9):957-60. [View Abstract]
  24. Ward MS, Lam KV, Cannell PK, Herrmann RP. Mycobacterial central venous catheter tunnel infection: a difficult problem. Bone Marrow Transplant. 1999 Aug. 24(3):325-9. [View Abstract]
  25. Smith S, Taylor GD, Fanning EA. Chronic cutaneous Mycobacterium haemophilum infection acquired from coral injury. Clin Infect Dis. 2003 Oct 1. 37(7):e100-1. [View Abstract]
  26. Modi D, Pyatetsky D, Edward DP, Ulanski LJ, Pursell KJ, Tessler HH, et al. Mycobacterium haemophilum: a rare cause of endophthalmitis. Retina. 2007 Oct. 27(8):1148-51. [View Abstract]
  27. Keller M, Mak A, Thibert L, Rene P, Klein MB. Mycobacterium haemophilum epididymal abscess in a renal transplant patient. J Clin Microbiol. 2008 Jul. 46(7):2459-60. [View Abstract]
  28. Buppajarntham A, Apisarnthanarak A, Rutjanawech S, Khawcharoenporn T. Central nervous system infection due to Mycobacterium haemophilum in a patient with acquired immunodeficiency syndrome. Int J STD AIDS. 2015 Mar. 26 (4):288-90. [View Abstract]
  29. Merkler AE, Parlitsis G, Patel S, Oliveira C, Lavi E, Schuetz A, et al. Infection of the optic apparatus and hypothalamus by Mycobacterium haemophilum. Neurology. 2014 Aug 12. 83 (7):659-60. [View Abstract]
  30. Rajpara A, Sri J, Driscoll M. Mycobacterium haemophilum: Cutanoeus nodules in a renal transplant patient. Dermatol Online J. 2010. 16(7):3. [View Abstract]
  31. Kelley CF, Armstrong WS, Eaton ME. Disseminated Mycobacterium haemophilum infection. Lancet Infect Dis. 2011 Jul. 11(7):571-8. [View Abstract]
  32. Bekou V, Büchau A, Flaig MJ, Ruzicka T, Hogardt M. Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man. BMC Dermatol. 2011. 11:3. [View Abstract]
  33. Clement CG, Loeffelholz MJ, Eltorky MA, Tang YW, Williams-Bouyer N. Mycobacterium haemophilum and Histoplasma capsulatum coinfection in a renal transplant patient. J Clin Microbiol. 2011 Sep. 49(9):3425-8. [View Abstract]
  34. Takeo N, Hatano Y, Okamoto O, Saruwatari K, Nakanaga K, Ishii N. Case of Mycobacterium haemophilum infection in a Japanese renal transplant patient and a review of Japanese cases. J Dermatol. 2012 Mar 14. [View Abstract]
  35. Shih JY, Hsueh PR, Chang YL, Lin SF, Teng LJ, Luh KT. Pyomyositis due to Mycobacterium haemophilum in a patient with polymyositis and long-term steroid use. Clin Infect Dis. 1998 Feb. 26(2):505-7. [View Abstract]
  36. Abbott MR, Smith DD. The pathogenic effects of Mycobacterium haemophilum in immunosuppressed albino mice. J Med Microbiol. 1980 Nov. 13(4):535-40. [View Abstract]
  37. Wang SX, Sng LH, Leong HN, Tan BH. Direct identification of Mycobacterium haemophilum in skin lesions of immunocompromised patients by PCR-restriction endonuclease analysis. J Clin Microbiol. 2004 Jul. 42(7):3336-8. [View Abstract]
  38. Lau SK, Curreem SO, Ngan AH, Yeung CK, Yuen KY, Woo PC. First report of disseminated Mycobacterium skin infections in two liver transplant recipients and rapid diagnosis by hsp65 gene sequencing. J Clin Microbiol. 2011 Nov. 49(11):3733-8. [View Abstract]
  39. Lindeboom JA, Bruijnesteijn van Coppenraet LE, van Soolingen D, Prins JM, Kuijper EJ. Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev. 2011 Oct. 24(4):701-17. [View Abstract]
  40. Lindeboom JA. Facial Skin Lesions in Children Caused by Nontuberculous Mycobacteria. Pediatr Dermatol. 2016 Mar-Apr. 33 (2):196-9. [View Abstract]
  41. Bruijnesteijn van Coppenraet LE, Kuijper EJ, Lindeboom JA, Prins JM, Claas EC. Mycobacterium haemophilum and lymphadenitis in children. Emerg Infect Dis. 2005 Jan. 11(1):62-8. [View Abstract]
  42. Münster S, Zustin J, Derlin T. Atypical mycobacteriosis caused by Mycobacterium haemophilum in an immunocompromised patient: diagnosis by (18)F-FDG PET/CT. Clin Nucl Med. 2013 Apr. 38(4):e194-5. [View Abstract]
  43. Lindeboom JA, Kuijper EJ, Prins JM, Bruijnesteijn van Coppenraet ES, Lindeboom R. Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis. 2006 Dec 15. 43(12):1547-51. [View Abstract]
  44. Lindeboom JA. Surgical treatment for nontuberculous mycobacterial (NTM) cervicofacial lymphadenitis in children. J Oral Maxillofac Surg. 2012 Feb. 70(2):345-8. [View Abstract]
  45. Touma Z, Haddad A, Gladman DD, Uleryk EM, Urowitz MB. Skin nontuberculous mycobacterial infection in systemic lupus erythematosus: an unusual skin infection mimicking lupus vasculitis. Semin Arthritis Rheum. 2013 Apr. 42(5):498-506. [View Abstract]
  46. Armstrong D, Kiehn T, Boone MW. From the Centers for Disease Control. Mycobacterium haemophilum infections--New York City metropolitan area, 1990-1991. JAMA. 1992 Jan 8. 267(2):215-6. [View Abstract]
  47. Cohen YH, Amir J, Ashkenazi S, Eidlitz-Markus T, Samra Z, Kaufmann L, et al. Mycobacterium haemophilum and lymphadenitis in immunocompetent children, Israel. Emerg Infect Dis. 2008 Sep. 14(9):1437-9. [View Abstract]
  48. Da Mata O, Pérez Alfonzo R, Natera I, Sucre Rdel C, Bello T, de Waard JH. The diagnosis of two cases of cutaneous ulcer caused by infection with Mycobacterium haemophilum: direct identification in a clinical sample by polymerase chain reaction-restriction endonuclease analysis. Int J Dermatol. 2008 Aug. 47(8):820-3. [View Abstract]
  49. Dever LL, Martin JW, Seaworth B, Jorgensen JH. Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS. Clin Infect Dis. 1992 Jun. 14(6):1195-200. [View Abstract]
  50. Elsayed S, Read R. Mycobacterium haemophilum osteomyelitis: case report and review of the literature. BMC Infect Dis. 2006. 6:70. [View Abstract]
  51. Holladay KL, Carmichael JK. Mycobacterium haemophilum cellulitis and osteomyelitis in a man with AIDS. J Am Board Fam Pract. 1996 Mar-Apr. 9(2):122-4. [View Abstract]
  52. Kamboj M, Louie E, Kiehn T, Papanicolaou G, Glickman M, Sepkowitz K. Mycobacterium haemophilum infection after alemtuzumab treatment. Emerg Infect Dis. 2008 Nov. 14(11):1821-3. [View Abstract]
  53. Lee WJ, Kang SM, Sung H, Won CH, Chang SE, Lee MW, et al. Non-tuberculous mycobacterial infections of the skin: a retrospective study of 29 cases. J Dermatol. 2010 Nov. 37(11):965-72. [View Abstract]
  54. Lefkowitz RA, Singson RD. Considering Mycobacterium haemophilum in the differential diagnosis for lytic bone lesions in AIDS patients who present with ulcerating skin lesions. Skeletal Radiol. 1998 Jun. 27(6):334-6. [View Abstract]
  55. Lin JH, Chen W, Lee JY, Yan JJ, Huang JJ. Disseminated cutaneous Mycobacterium haemophilum infection with severe hypercalcaemia in a failed renal transplant recipient. Br J Dermatol. 2003 Jul. 149(1):200-2. [View Abstract]
  56. Lott JP, Werth VP, Kovarik CL. Cutaneous Mycobacterium haemophilum infection in iatrogenically immunocompromised patients without transplantation. J Am Acad Dermatol. 2008 Jul. 59(1):139-42. [View Abstract]
  57. Phowthongkum P, Puengchitprapai A, Udomsantisook N, Tumwasorn S, Suankratay C. Spindle cell pseudotumor of the brain associated with Mycobacterium haemophilum and Mycobacterium simiae mixed infection in a patient with AIDS: the first case report. Int J Infect Dis. 2008 Jul. 12(4):421-4. [View Abstract]
  58. Plemmons RM, McAllister CK, Garces MC, Ward RL. Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: case report and analysis of interactions among clarithromycin, rifampin, and cyclosporine. Clin Infect Dis. 1997 May. 24(5):995-7. [View Abstract]
  59. Sagi L, Leshem E, Barzilai A, Baum S, Har-Zahav Y, Rahav G. Mycobacterium haemophilum infection presenting as bilateral cellulitis and annular lesion in a heart transplant recipient. Isr Med Assoc J. 2010 Jan. 12(1):57-8. [View Abstract]
  60. Samra Z, Kaufmann L, Zeharia A, Ashkenazi S, Amir J, Bahar J, et al. Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy. J Clin Microbiol. 1999 Mar. 37(3):832-4. [View Abstract]
  61. Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev. 1996 Oct. 9(4):435-47. [View Abstract]
  62. Seitz CS, Trautemann A, Bröcker EB, Abele-Horn M, Goebeler M. Skin nodules in rheumatoid arthritis due to infection with Mycobacterium haemophilum. Acta Derm Venereol. 2008. 88(4):428-9. [View Abstract]
  63. Straus WL, Ostroff SM, Jernigan DB, Kiehn TE, Sordillo EM, Armstrong D, et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med. 1994 Jan 15. 120(2):118-25. [View Abstract]
  64. Tan HH, Tan A, Theng C, Ng SK. Cutaneous Mycobacterium haemophilum infections in immunocompromised patients in a dermatology clinic in Singapore. Ann Acad Med Singapore. 2004 Jul. 33(4):532-6. [View Abstract]
  65. van Coppenraet LS, Smit VT, Templeton KE, Claas EC, Kuijper EJ. Application of real-time PCR to recognize atypical mycobacteria in archival skin biopsies: high prevalence of Mycobacterium haemophilum. Diagn Mol Pathol. 2007 Jun. 16(2):81-6. [View Abstract]
  66. White DA, Kiehn TE, Bondoc AY, Massarella SA. Pulmonary nodule due to Mycobacterium haemophilum in an immunocompetent host. Am J Respir Crit Care Med. 1999 Oct. 160(4):1366-8. [View Abstract]
  67. Yarrish RL, Shay W, LaBombardi VJ, Meyerson M, Miller DK, Larone D. Osteomyelitis caused by Mycobacterium haemophilum: successful therapy in two patients with AIDS. AIDS. 1992 Jun. 6(6):557-61. [View Abstract]